Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4bqr | IBH | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4bqr | IBH | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 1.000 | |
| 4bqp | VMY | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.643 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.515 | |
| 4trj | 665 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.500 | |
| 4tzk | 641 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.492 | |
| 3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.488 | |
| 3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.477 | |
| 3gob | HXX | DdmC | / | 0.471 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.468 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.466 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.464 | |
| 1ykd | CMP | Adenylate cyclase | / | 0.462 | |
| 3fc6 | REA | Retinoic acid receptor RXR-alpha | / | 0.462 | |
| 3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.462 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.462 | |
| 3sn6 | P0G | Beta-2 adrenergic receptor | / | 0.462 | |
| 1r2j | FAD | FkbI | / | 0.461 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.460 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.460 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.460 | |
| 1ikv | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.457 | |
| 4jaz | STL | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 2xc3 | RT8 | Steroid C26-monooxygenase | 1.14.13.141 | 0.455 | |
| 1ppj | ANY | Cytochrome b | / | 0.454 | |
| 4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.454 | |
| 2xy9 | 3ES | Angiotensin-converting enzyme | 3.2.1 | 0.453 | |
| 4bbh | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.452 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.452 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.451 | |
| 2wyv | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.451 | |
| 3mpj | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.451 | |
| 1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.450 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
| 2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.449 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
| 3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.448 | |
| 4a1z | ADP | Kinesin-like protein KIF11 | / | 0.448 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.447 | |
| 2yne | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.447 | |
| 3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.447 | |
| 3h0a | 9RA | Retinoic acid receptor RXR-alpha | / | 0.447 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.447 | |
| 4up3 | NDP | Thioredoxin reductase | / | 0.447 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
| 1uml | FR4 | Adenosine deaminase | 3.5.4.4 | 0.446 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.446 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
| 2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 1f4f | TP3 | Thymidylate synthase | / | 0.444 | |
| 1uy8 | PU5 | Heat shock protein HSP 90-alpha | / | 0.444 | |
| 3b9l | AZZ | Serum albumin | / | 0.444 | |
| 3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 3ggg | NAD | Prephenate dehydrogenase | / | 0.444 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.444 | |
| 1gg5 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.443 | |
| 2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
| 3fal | REA | Retinoic acid receptor RXR-alpha | / | 0.443 | |
| 3r9u | FAD | Thioredoxin reductase | / | 0.443 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 1bws | NDP | GDP-L-fucose synthase | / | 0.442 | |
| 1fmj | RTL | Retinol dehydratase | / | 0.442 | |
| 1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.442 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.442 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.441 | |
| 2ync | YNC | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
| 3qai | XNN | Ketohexokinase | / | 0.441 | |
| 4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.441 | |
| 4ryv | ZEA | Protein LlR18A | / | 0.441 | |
| 4s0v | SUV | Orexin receptor type 2 | / | 0.441 | |
| 1bwl | FMN | NADPH dehydrogenase 1 | 1.6.99.1 | 0.440 | |
| 1knu | YPA | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
| 3unj | 0BX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 |